Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 111.07M P/E - EPS this Y 47.20% Ern Qtrly Grth -
Income -119.76M Forward P/E -1.73 EPS next Y 50.70% 50D Avg Chg 35.00%
Sales 9.99M PEG - EPS past 5Y - 200D Avg Chg 75.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -12.00%
Recommedations 1.40 Quick Ratio 0.71 Shares Outstanding 114.24M 52W Low Chg 284.00%
Insider Own 6.66% ROA -86.56% Shares Float 87.82M Beta 1.81
Inst Own 64.41% ROE - Shares Shorted/Prior 4.74M/3.79M Price 1.92
Gross Margin - Profit Margin - Avg. Volume 234,882 Target Price 11.60
Oper. Margin 3,149.63% Earnings Date May 9 Volume 1,911,233 Change 12.28%
About Applied Therapeutics, Inc.

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Applied Therapeutics, Inc. News
04/15/24 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
04/04/24 Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
03/28/24 UPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drug
03/28/24 Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
03/13/24 Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
03/08/24 Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
07:00 AM Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
02/28/24 FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
02/28/24 Applied Therapeutics Announces $100 Million Private Placement
02/28/24 Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
02/21/24 13 Best Booming Stocks to Buy Right Now
02/15/24 Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
01/18/24 We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully
01/04/24 Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
01/03/24 Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
11/09/23 Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ...
11/09/23 Applied Therapeutics Reports Third Quarter 2023 Financial Results
11/05/23 Applied Therapeutics, Inc. (NASDAQ:APLT) is definitely on the radar of institutional investors who own 38% of the company
11/02/23 Applied Therapeutics to Present at the UBS Biopharma Conference 2023
11/01/23 Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
APLT Chatroom

User Image wschi7767 Posted - 2 days ago

$APLT bumping to the afterhours action

User Image Overloaddd Posted - 2 days ago

$APLT BOOM 🀯 Up all week and the reversal is looking real good 😊

User Image Overloaddd Posted - 3 days ago

$APLT Reversal looking good πŸš€

User Image aless12 Posted - 3 days ago

@koalaballa I said the same with $APLT (+150%) Suit yourself πŸ˜‰

User Image FyCkD_FuNnY Posted - 04/30/24

$APLT They filed for the shareholders who bought the Private Placement at $7... Filed, I doubt they are selling for a LOSS...πŸ€¦β€β™‚οΈ Perceptive, Venrock, Janus and TangπŸ’ͺ

User Image FyCkD_FuNnY Posted - 04/30/24

$APLT Board is still dead with only 174 watchers since I first posted... All the facts are still true, check out previous posts for DD...🍻

User Image wschi7767 Posted - 04/29/24

$IBRX 2 the moon πŸš€πŸŒ™ $GERN $APLT r next

User Image Overloaddd Posted - 04/25/24

$APLT Just so you know the value of this stock πŸš€πŸš€πŸš€

User Image aless12 Posted - 04/25/24

$OCGN It’s like $APLT Next weeks will start increase and overcome price target 🎯 They have already Phase 3 for 2 drugs … Waiting EMA FOR EUROPE

User Image Overloaddd Posted - 04/24/24

$APLT Jesus today is an absolute bloodbath. 😒

User Image Blum_Chonks Posted - 04/23/24

$APLT....... https://www.forbes.com/sites/jakezamansky/2013/08/08/the-great-vampire-squid-keeps-on-sucking/?sh=47c5415e7df8

User Image astroflyery1 Posted - 04/21/24

$HRTX $STRO $APLT $MREO $SPY It's been a highly volatile week with stocks sinking on a number of news. Be it geopolitical headwinds or high inflation numbers. In the upcoming week we will see Big Tech reporting their earnings and it appears that the expectations are that they're really going to deliver again. This could give a healthy upside movement on global markets. I remain bullish.

User Image WallStreetIsNotEasy Posted - 04/19/24

$APLT Close the damn market already

User Image nevermind889 Posted - 04/19/24

$APLT over 2m volume before power hour.. pretty impressive with no news just the dumb market doing dumb things!

User Image FyCkD_FuNnY Posted - 04/19/24

$APLT So who SOLD, DCAed and or ADDed...πŸ‘ˆπŸ‘€πŸ¦

User Image nevermind889 Posted - 04/19/24

@WallStreetIsNotEasy hopefully we see some relief next week on $APLT when the option chain expire today! The market is a legit disaster. This hit green daily it's so crazy to see it not hold!

User Image nevermind889 Posted - 04/19/24

$APLT already doing 1x daily volume at 11am. hopefully all the shorts +bear will close their positions today!

User Image nevermind889 Posted - 04/19/24

$APLT witching day just need the shorts to cover and 5$ put option holder to take their $$$ so we can see better days

User Image WallStreetIsNotEasy Posted - 04/19/24

$APLT BUY, BUY at will folks as this company is de-risked with HUGE upside potential

User Image nevermind889 Posted - 04/19/24

$APLT Waiting on PRENDA for SORD! https://www.empr.com/home/news/drugs-in-the-pipeline/functional-improvement-seen-with-govorestat-in-sord-deficiency-trial/

User Image Overloaddd Posted - 04/18/24

$APLT - New Chief Commercial Officer with a great track record - 100 Million Dollar Private Placement for pipeline - FDA Approvals Incoming - Price Target is at $12-13 This is a easy buy + hold Bought in and not selling until this hits above 13!

User Image nevermind889 Posted - 04/17/24

$APLT "I am excited to join Applied Therapeutics as the company nears significant and transformative milestones,” said Mr. Hooks. β€œGovorestat has the potential to become the first and only treatment option for patients living with debilitating rare diseases. With registrational filings under review in the US and in Europe, this is a critical year for the company. Applied’s progress to date has been impressive and I look forward to working with the team to further its momentum with a primary focus on bringing govorestat to patients.” europe+fda will see this above 10! hodl strong longs! artificial dump today https://ir.appliedtherapeutics.com/

User Image nevermind889 Posted - 04/17/24

$APLT looks like ssr is on the way for tomorrow.. ouch

User Image nevermind889 Posted - 04/17/24

$APLT at least we were green yesterday. wtf is this morning raid today down -5.34% on no news

User Image FyCkD_FuNnY Posted - 04/15/24

$APLT Funding is GOOD... Dont forget that...πŸ‘‡πŸ‘€πŸ¦ https://www.globenewswire.com/news-release/2024/02/28/2836939/0/en/Applied-Therapeutics-Announces-100-Million-Private-Placement.html

User Image FyCkD_FuNnY Posted - 04/15/24

$APLT They want to Increase Auth Shares to 250m, I say know this time around... They will get another chance... "4. To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient votes in favor of the Authorized Shares Increase Proposal; and "

User Image FyCkD_FuNnY Posted - 04/15/24

$APLT Expecting to see anther 10%+ move down to the $4.40s Just Signed Dale Hooks as Chief Commercial Officer He has 227 Days till PDUFA, to get their Shit TogetherπŸš€ When he was Appointed CCO at CLVS, priced initially dropped by 50%+, then Rocketed 636%...🀫 When he joined RETA as VP of Global Commercial Operations, price hovered till Jumping 175%+/-... Years Later, Shareholders... Had to chance to get in under $40 before being Acquired by BioGen for $172.50/shareπŸ•΅οΈβ€β™‚οΈπŸ€« Thoughts on Dale Hooks...

User Image nevermind88 Posted - 04/15/24

$APLT much healthier volume hope we can see some upside. Market so volatile with yields and israel/Iran conflict. Ontop of feds fucking up weekly

User Image Overloaddd Posted - 04/15/24

$APLT Jesus, it had great support until now 😭 Hopefully we see a green day tomorrow

User Image nevermind889 Posted - 04/15/24

$APLT Surprisingly amount of volume compared to the last 2 weeks....150k share by 10am!

Analyst Ratings
RBC Capital Outperform Apr 11, 24
RBC Capital Outperform Mar 26, 24
UBS Buy Mar 15, 24
UBS Buy Mar 6, 24
Leerink Partners Outperform Feb 22, 24
Citigroup Buy Feb 16, 24
Baird Outperform Apr 25, 23
Citigroup Buy Apr 5, 23
Citigroup Buy Aug 17, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kanter Stacy J. Director Director Dec 01 Buy 2.1789 30,000 65,367 63,000 12/05/23
Shendelman Shoshana President and CEO President and CEO Nov 30 Sell 1.97 3,968 7,817 2,596,387 12/01/23
Perfetti Riccardo Chief Medical Office.. Chief Medical Officer Nov 30 Sell 1.97 1,583 3,119 692,341 12/01/23
Hansard Adam Chief Commercial Off.. Chief Commercial Officer Nov 30 Sell 1.97 965 1,901 381,790 12/01/23
ALEXANDRIA REAL ESTATE EQUITIE... 10% Owner 10% Owner Nov 02 Sell 2.32 247,258 573,639 5,580,077 11/06/23
Shendelman Shoshana President and CEO President and CEO Sep 27 Sell 2.70 115,632 312,206 2,600,355 09/29/23
Perfetti Riccardo Chief Medical Office.. Chief Medical Officer Sep 27 Sell 2.70 10,932 29,516 693,924 09/29/23
Hansard Adam Chief Commercial Off.. Chief Commercial Officer Sep 27 Sell 2.70 9,720 26,244 382,755 09/29/23
MARCUS JOEL S Director Director Sep 15 Option 1.05 12,375 12,994 453,414 09/19/23
Hansard Adam Chief Commercial Off.. Chief Commercial Officer Jan 11 Sell 0.91 4,495 4,090 92,475 01/13/23
Shendelman Shoshana President and CEO President and CEO Oct 12 Buy 0.5227 38,153 19,943 644,239 10/12/22
MARCUS JOEL S Director Director Apr 14 Option 7.35 48,982 360,018 67,435 09/16/22
MARCUS JOEL S Director Director Sep 14 Option 1.05 38,244 40,156 421,039 09/16/22
ALEXANDRIA REAL ESTATE EQUITIE... 10% Owner 10% Owner Jun 27 Buy 1 3,500,000 3,500,000 4,555,077 06/29/22
Mahadevan Chids See Remarks See Remarks May 16 Sell 1.65 905 1,493 9,800 05/18/22
Perfetti Riccardo Chief Medical Office.. Chief Medical Officer Mar 21 Buy 1.93 64,509 124,502 160,909 03/23/22
Shendelman Shoshana President and CEO President and CEO Sep 14 Buy 14.59 10,001 145,915 364,286 09/14/21